✦ LIBER ✦

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis

✍ Scribed by U. Martinowitz; A. Shapiro; D. V. Quon; M. Escobar; C. Kempton; P. W. Collins; P. Chowdary; M. Makris; P. M. Mannucci; M. Morfini; L. A. Valentino; E. Gomperts; M. Lee

Book ID: 114729095
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 124 KB
Volume: 18
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2012.02897.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Determination of minimal sampling time p

Determination of minimal sampling time points for reliable pharmacokinetic evaluation of recombinant factor VIII – an exploratory population pharmacokinetic analysis in paediatric patients suffering from severe haemophilia

✍ H. STASS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Clinical efficacy, safety and pharmacoki

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine® in previously treated patients with severe haemophilia B

✍ M. SERBAN; A. B. SKOTNICKI; M. COLOVIC; C. JINCA; A. KLUKOWSKA; P. LAGUNA; D. M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB